Human β1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage
Hakalahti, Anna E.; Vierimaa, Miia M.; Lilja, Minna K.; Kumpula, Esa-Pekka; Tuusa, Jussi T.; Petäjä-Repo, Ulla E. (2010-09-10)
Hakalahti, A. E., Vierimaa, M. M., Lilja, M. K., Kumpula, E.-P., Tuusa, J. T., & Petäjä-Repo, U. E. (2010). Human β1-Adrenergic Receptor Is Subject to Constitutive and Regulated N-terminal Cleavage. Journal of Biological Chemistry, 285(37), 28850–28861. https://doi.org/10.1074/jbc.m110.149989
This research was originally published in the Journal of Biological Chemistry. Hakalahti, A. E., Vierimaa, M. M., Lilja, M. K., Kumpula, E.-P., Tuusa, J. T., & Petäjä-Repo, U. E. Human β1-Adrenergic Receptor Is Subject to Constitutive and Regulated N-terminal Cleavage. J. Biol. Chem. 2010; 285:28850–28861. © by The American Society for Biochemistry and Molecular Biology.
https://rightsstatements.org/vocab/InC/1.0/
https://urn.fi/URN:NBN:fi-fe2019120445642
Tiivistelmä
Abstract
The β₁-adrenergic receptor (β₁AR) is the predominant βAR in the heart, mediating the catecholamine-stimulated increase in cardiac rate and force of contraction. Regulation of this important G protein-coupled receptor is nevertheless poorly understood. We describe here the biosynthetic profile of the human β₁AR and reveal novel features relevant to its regulation using an inducible heterologous expression system in HEK293i cells. Metabolic pulse-chase labeling and cell surface biotinylation assays showed that the synthesized receptors are efficiently and rapidly transported to the cell surface. The N terminus of the mature receptor is extensively modified by sialylated mucin-type O-glycosylation in addition to one N-glycan attached to Asn15. Furthermore, the N terminus was found to be subject to limited proteolysis, resulting in two membrane-bound C-terminal fragments. N-terminal sequencing of the fragments identified two cleavage sites between Arg³¹ and Leu³² and Pro⁵² and Leu⁵³, which were confirmed by cleavage site and truncation mutants. Metalloproteinase inhibitors were able to inhibit the cleavage, suggesting that it is mediated by a matrix metalloproteinase or a disintegrin and metalloproteinase (ADAM) family member. Most importantly, the N-terminal cleavage was found to occur not only in vitro but also in vivo. Receptor activation mediated by the βAR agonist isoproterenol enhanced the cleavage in a concentration- and time-dependent manner, and it was also enhanced by direct stimulation of protein kinase C and adenylyl cyclase. Mutation of the Arg³¹–Leu³² cleavage site stabilized the mature receptor. We hypothesize that the N-terminal cleavage represents a novel regulatory mechanism of cell surface β₁ARs.
Kokoelmat
- Avoin saatavuus [34164]